Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Tse, Winona
PROSPER, NCT06355531: A Study to Assess the Efficacy, Safety, and Pharmacokinetics of FNP-223 to Slow Progression of Progressive Supranuclear Palsy (PSP)	Recruiting	2	220	Europe, US	FNP-223, Placebo	Ferrer Internacional S.A.	Progressive Supranuclear Palsy	11/26	11/26
NCT06006247: Early Parkinson's Disease Monotherapy With CVN424	Active, not recruiting	2	62	US	CVN424 150 mg, Placebo	Cerevance Beta, Inc.	Parkinson's Disease	10/24	02/25